Antibody Information
General Information of This Antibody
| Antibody ID | ANI0UBWKA |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | DT390 |
|||||
| Antibody Type | Monoclonal antibody (mAb) |
|||||
| Antibody Subtype | Humanized IgG |
|||||
| Antigen Name | C-C chemokine receptor type 4 (CCR4) |
Antigen Info | ||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
IL2-CCR4 immunotoxin [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
1.57 pM
|
Positive CCR4 expression (CCR4 +++/++) | ||
| Method Description |
In vitro efficacy comparison of the CCR4 IT vs IL2 fusion toxin to human CCR4+ CTCL Hut102/6TG using luminescent cell viability assay.
|
||||
| In Vitro Model | Cutaneous T cell lymphoma | HUT102/6TG cells | Homo sapiens | ||
IL2-CCR4 IT [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
6.30 pM
|
Positive CCR4 expression (CCR4 +++/++) | ||
| Method Description |
In vitro efficacy comparison of the CCR4 IT vs IL2 fusion toxin to human CCR4+ CTCL Hut102/6TG using luminescent cell viability assay.
|
||||
| In Vitro Model | Cutaneous T cell lymphoma | HUT102/6TG cells | Homo sapiens | ||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.
